Tafalgie Therapeutics
Created in 2020
Up & running (A)
Existing signals show a regular activitySocial networks
1,465Activities
Technologies
Entity types
Location
163 Av. de Luminy, 13009 Marseille, France
Marseille
France
Employees
Scale: 11-50
Estimated: 17
SIREN
891031148Engaged corporates
36
10 10Added in Motherbase
1 year, 3 months ago
biotech Value proposition
[Automatic translation follows] Research Contributing to Health and Well-Being: innovative polypeptides for the prevention & amp; Treatment of Pain
Tafalgie Therapeutics is a spin-off company of the CNRS and AMU engaged in biopharmaceutical research and engaged in the development of a new scientific approach for new generation treatments based on a break in rupture: a mechanism of action derived from an endogenous secreted protein capable of modulating pain signals.
Tafalgia Therapeutics wishes to become the reference actor in the field of pain, by designing and offering new pharmaceutical active ingredients based on the development of polypeptides derived from TAFA4.
In Tafalgie Therapeutics, we aim to develop more effective long -term treatments, better tolerated, without addiction, to relieve acute pain, whether light, moderate or severe, and to prevent chronic pain, and to deliver these treatments to patients. In the medium term, we aim to conclude partnership agreements with large pharmaceutical companies or specialized international distributors capable of putting products based on TAFA4 technology on the market.
Biotechnology, pharmacology, medical, research, sciences, and laboratoryOriginal language
Research contributing to health and well-being : innovative polypeptides for the prevention & treatment of pain
Tafalgie Therapeutics est une société spin-off du CNRS et d'AMU engagée dans la recherche biopharmaceutique et engagée dans le développement d'une nouvelle approche scientifique pour des traitements de nouvelle génération basés sur une innovation de rupture : un mécanisme d'action dérivé d'une protéine sécrétée endogène capable de moduler les signaux de la douleur.
Tafalgie Therapeutics souhaite devenir l'acteur de référence dans le domaine de la douleur, en concevant et en proposant de nouveaux principes actifs pharmaceutiques basés sur le développement de polypeptides dérivés de la TAFA4.
Chez Tafalgie Therapeutics, nous visons à développer des traitements à long terme plus efficaces, mieux tolérés, sans accoutumance, pour soulager la douleur aiguë, qu'elle soit légère, modérée ou sévère, et pour prévenir la douleur chronique, et à délivrer ces traitements aux patients. A moyen terme, nous visons à conclure des accords de partenariat avec de grandes sociétés pharmaceutiques ou des distributeurs internationaux spécialisés capables de mettre sur le marché des produits basés sur la technologie TAFA4.
biotechnologie, pharmacologie, medical, recherche, sciences, and laboratoire
Tafalgie Therapeutics - Innovating therapeutic solution for chronic pain
https://tafalgie.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 La French Tech Aix-Marseille Région Sud French Tech, Software Development | La French Tech Aix-Marseille Région Sud French Tech, Software Development | Other 21 Mar 2024 | | |
 INIZIÀ - Incubateur Territorial des Entreprises Innovantes de Corse Business Consulting and Services | INIZIÀ - Incubateur Territorial des Entreprises Innovantes de Corse Business Consulting and Services | Other 31 Oct 2023 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 13 Mar 2025 | | |
 Région Sud - Provence-Alpes-Côte d'Azur National and local authorities, Government Administration | Région Sud - Provence-Alpes-Côte d'Azur National and local authorities, Government Administration | Other 19 Sep 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 15 Apr 2024 | | |
 OECD - OCDE International development, International Affairs | OECD - OCDE International development, International Affairs | Other 31 Oct 2023 | | |
 SATT Sud-Est Research, National and local authorities, Research Services | SATT Sud-Est Research, National and local authorities, Research Services | Other 13 Mar 2025 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 15 Nov 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 19 Sep 2024 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 9 Feb 2023 | | |